149 related articles for article (PubMed ID: 20077594)
1. No hyperalgesia following opioid withdrawal after the oripavine derivative etorphine compared to remifentanil and sufentanil.
Freye E; Levy JV
Eur J Anaesthesiol; 2010 Feb; 27(2):174-80. PubMed ID: 20077594
[TBL] [Abstract][Full Text] [Related]
2. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
Freye E; Neruda B; Smith OW
Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
[TBL] [Abstract][Full Text] [Related]
3. 14-methoxymetopon, a potent opioid, induces no respiratory depression, less sedation, and less bradycardia than sufentanil in the dog.
Freye E; Schmidhammer H; Latasch L
Anesth Analg; 2000 Jun; 90(6):1359-64. PubMed ID: 10825321
[TBL] [Abstract][Full Text] [Related]
4. Effects of naloxone on opioid-induced hyperalgesia and tolerance to remifentanil under sevoflurane anesthesia in rats.
Aguado D; Abreu M; Benito J; Garcia-Fernandez J; Gómez de Segura IA
Anesthesiology; 2013 May; 118(5):1160-9. PubMed ID: 23407105
[TBL] [Abstract][Full Text] [Related]
5. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
6. Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans.
Koppert W; Angst M; Alsheimer M; Sittl R; Albrecht S; Schüttler J; Schmelz M
Pain; 2003 Nov; 106(1-2):91-9. PubMed ID: 14581115
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance.
Zhao M; Joo DT
Anesthesiology; 2008 Aug; 109(2):308-17. PubMed ID: 18648240
[TBL] [Abstract][Full Text] [Related]
8. Comparison of target-controlled infusion of sufentanil and remifentanil in blunting hemodynamic response to tracheal intubation.
Yeganeh N; Roshani B; Latifi H; Almasi A
J Inj Violence Res; 2013 Jul; 5(2):101-7. PubMed ID: 23416718
[TBL] [Abstract][Full Text] [Related]
9. Small doses of remifentanil or sufentanil for blunting cardiovascular changes induced by tracheal intubation: a double-blind comparison.
Casati A; Fanelli G; Albertin A; Deni F; Danelli G; Grifoni F; Torri G
Eur J Anaesthesiol; 2001 Feb; 18(2):108-12. PubMed ID: 11270019
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids.
Korak-Leiter M; Likar R; Oher M; Trampitsch E; Ziervogel G; Levy JV; Freye EC
Intensive Care Med; 2005 Mar; 31(3):380-7. PubMed ID: 15714323
[TBL] [Abstract][Full Text] [Related]
11. Opioid infusions at different times of the day produce varying degrees of opioid-induced hyperalgesia.
Shu B; Liu H; Zheng X; He J; Wu Y; Chen J; Chen Y; Tian H; Ju D; Huang H; Duan G
Br J Anaesth; 2023 Dec; 131(6):1072-1081. PubMed ID: 37821342
[TBL] [Abstract][Full Text] [Related]
12. Intravenous infusion of remifentanil induces transient withdrawal hyperalgesia depending on administration duration in rats.
Ishida R; Nikai T; Hashimoto T; Tsumori T; Saito Y
Anesth Analg; 2012 Jan; 114(1):224-9. PubMed ID: 22025495
[TBL] [Abstract][Full Text] [Related]
13. Influence of intraoperative remifentanil and sufentanil on sensory perception: a randomized trial.
Ohnesorge H; Alpes A; Baron R; Gierthmühlen J
Curr Med Res Opin; 2016 Nov; 32(11):1797-1805. PubMed ID: 27388980
[TBL] [Abstract][Full Text] [Related]
14. Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence.
Shen KF; Crain SM
Brain Res; 1994 Feb; 636(2):286-97. PubMed ID: 8012813
[TBL] [Abstract][Full Text] [Related]
15. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal.
Angst MS; Koppert W; Pahl I; Clark DJ; Schmelz M
Pain; 2003 Nov; 106(1-2):49-57. PubMed ID: 14581110
[TBL] [Abstract][Full Text] [Related]
16. Influence of intraoperative opioid on postoperative pain and pulmonary function after laparoscopic gastric banding: remifentanil TCI vs sufentanil TCI in morbid obesity.
De Baerdemaeker LE; Jacobs S; Pattyn P; Mortier EP; Struys MM
Br J Anaesth; 2007 Sep; 99(3):404-11. PubMed ID: 17606479
[TBL] [Abstract][Full Text] [Related]
17. Amitriptyline, minocycline and maropitant reduce the sevoflurane minimum alveolar concentration and potentiate remifentanil but do not prevent acute opioid tolerance and hyperalgesia in the rat: a randomised laboratory study.
Aguado D; Abreu M; Benito J; García-Fernández J; Gómez de Segura IA
Eur J Anaesthesiol; 2015 Apr; 32(4):248-54. PubMed ID: 24849503
[TBL] [Abstract][Full Text] [Related]
18. The endogenous opioid system is not involved in modulation of opioid-induced hyperalgesia.
Chu LF; Dairmont J; Zamora AK; Young CA; Angst MS
J Pain; 2011 Jan; 12(1):108-15. PubMed ID: 20864417
[TBL] [Abstract][Full Text] [Related]
19. Questioning the cardiocirculatory excitatory effects of opioids under volatile anaesthesia.
Docquier MA; Lavand'homme P; Boulanger V; Collet V; De Kock M
Br J Anaesth; 2004 Sep; 93(3):408-13. PubMed ID: 15220166
[TBL] [Abstract][Full Text] [Related]
20. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
Shen KF; Crain SM
Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
